Tandem [4 + 2]/[3 + 2] Cycloadditions of Nitroalkenes. 12. Synthesis of (-)-Platynecine.
Tandem [4 + 2]/[3 + 2] Cycloadditions of Nitroalkenes. 12. Synthesis of (-)-Platynecine.
复制标题
DOI:
10.1021/jo961919x
复制
发表时间:
1997-01
期刊:
影响因子:
--
通讯作者:
S. Denmark;D. Parker;J. Dixon
中科院分区:
文献类型:
--
作者:
S. Denmark;D. Parker;J. Dixon
Pyrrolizidine alkaloids are attractive targets for synthesis due to their structural diversity and interesting biological properties. 1 We have developed a highly versatile method for the construction of pyrrolizidine frameworks through the use of the tandem [4+ 2]/[3+ 2] cycloaddition of nitroalkenes. 2 This reaction has served admirably as the key step in the synthesis of several pyrrolizidines including (-)-hastanecine (1), 3 (-)-rosmarinecine (2), 4 and (+)-crotanecine (3), 5 Figure 1. A remarkable feature of these syntheses is the use of an enantiomerically pure vinyl ether to control the absolute configuration of the target molecules. Additionally, the intramolecular nature of the [3+ 2] cycloaddition and the length and configuration of the tether are used to control the relative configuration of the critical centers. Thus, in (-)-rosmarinecine (2), the all-cis relationship between C (1), C (7a), and C (7) is established in the [3+ 2] cycloaddition. This same relationship (also in an absolute sense) exists in (-)-platynecine (4), which implied that deoxygenation (instead of inversion4) at C (6) would provide access to this simpler pyrrolizidine congener from a common synthetic intermediate. This paper describes the synthesis of (-)-platynecine in four steps from an advanced intermediate in the (-)-rosmarinecine synthesis.(-)-Platynecine (4) was first isolated in 1935 from Senecio Platyphyllusis6 and is the necine base portion of several pyrrolizidine alkaloids including platyphyllin, 6 neoplatyphilline, 7 bulgarsenine, 8 nemorensine, 9 retroisosenine, 8 mulgediifoline, 10 and ligularinine. 11 The synthesis of platynecine (4) has been reported in racemic form12 as well as three times in enantiomerically enriched form. 13